Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-/STAT1/Smad7 pathway.
Briefly

This website serves for information purposes only and does not diagnose, treat, cure, mitigate, or prevent any disease or medical condition.
Before starting any treatment regimen, consult a licensed healthcare professional for advice.
Read at Greenmedinfo
[
|
]